newsfilter
← Latest News
GlobeNewswire·

Sigilon Therapeutics Presents Preclinical Data at the 16th International Symposium on MPS and Related Diseases

CAMBRIDGE, Mass., July 23, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported resul